Fierce Biotech January 8, 2024
Andrea Park

After scoring an FDA nod last spring allowing updated versions of its continuous glucose monitors to be integrated into automated insulin delivery systems, Abbott has selected the first such system to pair with its FreeStyle Libre technology.

The FreeStyle Libre 2 Plus CGM will now be compatible with Tandem Diabetes Care’s t:slim X2 insulin pump and Control-IQ algorithm, the companies announced during the annual J.P. Morgan Healthcare Conference in San Francisco on Monday.

Though this marks the first automated insulin delivery partnership for the FreeStyle Libre technology, Abbott isn’t the first CGM maker to team up with Tandem. Last month, the t:slim X2 became the first automated insulin pump to pair with the Dexcom G7 sensor; it had previously been...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, Medical Devices, Trends
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio
Medicare Coverage Of Medical Technologies In A New Era
This year's top congressional medical technology priorities

Share This Article